SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mario Rizzetto, Antonina Smedile, Pegylated interferon therapy of chronic hepatitis D: In need of revision, Hepatology, 2015, 61, 4
  2. 2
    B. Calle Serrano, A. Großhennig, M. Homs, B. Heidrich, A. Erhardt, K. Deterding, J. Jaroszewicz, B. Bremer, A. Koch, M. Cornberg, M. P. Manns, M. Buti, H. Wedemeyer, Development and evaluation of a baseline-event-anticipation score for hepatitis delta, Journal of Viral Hepatitis, 2014, 21, 11
  3. 3
    Alessia Ciancio, Mario Rizzetto, Chronic hepatitis D at a standstill: where do we go from here?, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 1, 68

    CrossRef

  4. You have free access to this content4
    Mario Rizzetto, Current management of delta hepatitis, Liver International, 2013, 33,
  5. 5
    A. Katsoulidou, E. Manesis, C. Rokka, C. Issaris, A. Pagoni, V. Sypsa, A. Hatzakis, Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D, Journal of Viral Hepatitis, 2013, 20, 4
  6. 6
    Carolina Alves, Cristina Branco, Celso Cunha, Hepatitis Delta Virus: A Peculiar Virus, Advances in Virology, 2013, 2013, 1

    CrossRef

  7. 7
    Patrizia Burra, Giacomo Germani, Renè Adam, Vincent Karam, Alfredo Marzano, Pietro Lampertico, Mauro Salizzoni, Franco Filipponi, Jurgen L. Klempnauer, Denis Castaing, Murat Kilic, Luciano De Carlis, Peter Neuhaus, Sezai Yilmaz, Andreas Paul, Antonio D. Pinna, Andrew K. Burroughs, Francesco P. Russo, Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes, Journal of Hepatology, 2013, 58, 2, 287

    CrossRef

  8. 8
    Fulya Gunsar, Treatment of delta hepatitis, Expert Review of Anti-infective Therapy, 2013, 11, 5, 489

    CrossRef

  9. You have free access to this content9
    Heiner Wedemeyer, Svenja Hardtke, Michael P. Manns, Treatment of hepatitis Delta, Clinical Liver Disease, 2013, 2, 6
  10. 10
    Nada Melhem, Soha Yazbek, Sami Ramia, Hepatitis D in the Middle East and North Africa (MENA): Update and Challenges Ahead, Current Hepatitis Reports, 2012, 11, 4, 272

    CrossRef

  11. 11
    Antonina Smedile, Mario Rizzetto, HDV: Thirty years later, Digestive and Liver Disease, 2011, 43, S15

    CrossRef

  12. You have free access to this content12
    Heiner Wedemeyer, Hepatitis D revival, Liver International, 2011, 31,
  13. 13
    Heiner Wedemeyer, Michael P. Manns, Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 1, 31

    CrossRef

  14. 14
    Grazia Anna Niro, Antonina Smedile, Antonio Massimo Ippolito, Alessia Ciancio, Rosanna Fontana, Antonella Olivero, Maria Rosa Valvano, Maria Lorena Abate, Domenica Gioffreda, Gian Paolo Caviglia, Mario Rizzetto, Angelo Andriulli, Outcome of chronic delta hepatitis in Italy: A long-term cohort study, Journal of Hepatology, 2010, 53, 5, 834

    CrossRef

  15. 15
    Heiner Wedemeyer, Re-emerging interest in hepatitis delta: New insights into the dynamic interplay between HBV and HDV, Journal of Hepatology, 2010, 52, 5, 627

    CrossRef

  16. 16
    Joel Gozlan, Karine Lacombe, Elyanne Gault, Gilles Raguin, Pierre-Marie Girard, Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV, Journal of Hepatology, 2009, 50, 2, 432

    CrossRef

  17. 17
    Fulya Gunsar, Delta hepatitis, Expert Review of Anti-infective Therapy, 2009, 7, 5, 499

    CrossRef

  18. 18
    Mario Rizzetto, Hepatitis D: Thirty years after, Journal of Hepatology, 2009, 50, 5, 1043

    CrossRef

  19. 19
    Chul-Yong Park, Sang-Heun Oh, Sang Min Kang, Yun-Sook Lim, Soon B. Hwang, Hepatitis delta virus large antigen sensitizes to TNF-α-induced NF-κB signaling, Molecules and Cells, 2009, 28, 1, 49

    CrossRef

  20. 20
    Marion G. Peters, Special populations with hepatitis B virus infection, Hepatology, 2009, 49, S5
  21. 21
    Samir Dervisevic, Deenan Pillay, Ayliffe's Control of Healthcare-Associated Infection Fifth Edition, 2009,

    CrossRef

  22. 22
    G. Carosi, M. Rizzetto, Treatment of chronic hepatitis B: Recommendations from an Italian workshop, Digestive and Liver Disease, 2008, 40, 8, 603

    CrossRef

  23. 23
    Gregor Caspari, Wolfram H. Gerlich, Klinische Infektiologie, 2008,

    CrossRef

  24. 24
    Markus Cornberg, Michael P. Manns, Ulrike Protzer, Klinische Infektiologie, 2008,

    CrossRef

  25. 25
    A. Mele, A. Mariano, M. E. Tosti, T. Stroffolini, R. Pizzuti, G. Gallo, P. Ragni, C. Zotti, P. Lopalco, F. Curtale, E. Balocchini, E. Spada, Acute Hepatitis Delta Virus Infection in Italy: Incidence and Risk Factors after the Introduction of the Universal Anti-Hepatitis B Vaccination Campaign, Clinical Infectious Diseases, 2007, 44, 3, e17

    CrossRef

  26. 26
    S. Pol, Épidémiologie, histoire naturelle et traitements de l'infection virale delta, EMC - Hépatologie, 2007, 2, 1, 1

    CrossRef

  27. 27
    Elif S. Koytak, Cihan Yurdaydin, Jeffrey S. Glenn, Hepatitis D, Current Treatment Options in Gastroenterology, 2007, 10, 6, 456

    CrossRef

  28. 28
    Heiner Wedemeyer, Benjamin Heidrich, Michael P. Manns, Hepatitis D virus infection—Not a vanishing disease in Europe!, Hepatology, 2007, 45, 5
  29. 29
    Soo–Ho Choi, Sook–Hyang Jeong, Soon B. Hwang, Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis, Gastroenterology, 2007, 132, 1, 343

    CrossRef

  30. 30
    Lucio Caccamo, Francesca Agnelli, Paolo Reggiani, Umberto Maggi, M Francesca Donato, Stefano Gatti, Giovanni Paone, Ernesto Melada, Giorgio Rossi, Role of Lamivudine in the Posttransplant Prophylaxis of Chronic Hepatitis B Virus and Hepatitis Delta Virus Coinfection, Transplantation, 2007, 83, 10, 1341

    CrossRef

  31. 31
    P. Farci, L. Chessa, C. Balestrieri, G. Serra, M. E. Lai, Treatment of chronic hepatitis D, Journal of Viral Hepatitis, 2007, 14,
  32. 32
    Paul D. Berk, An editor's look-back, Hepatology, 2006, 43, S1
  33. 33
    Corinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, Emmanuel Gordien, Michelle Martinot-Peignoux, Nathalie Boyer, Bach-Nga Pham, Sarah Maylin, Pierre Bedossa, Paul Dény, Patrick Marcellin, Elyanne Gault, Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up, Hepatology, 2006, 44, 3
  34. 34
    D. Hartwig, C. Schütte, J. Warnecke, I. Dorn, H. Hennig, H. Kirchner, P. Schlenke, The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-α-stimulated host cells, Journal of Viral Hepatitis, 2006, 13, 3
  35. 35
    Patrizia Farci, Treatment of chronic hepatitis D: New advances, old challenges, Hepatology, 2006, 44, 3
  36. 36
    Andreas Erhardt, Wolfram Gerlich, Christine Starke, Ulrike Wend, Andreas Donner, Abdurrahman Sagir, Tobias Heintges, Dieter Häussinger, Treatment of chronic hepatitis delta with pegylated interferon-α2b, Liver International, 2006, 26, 7
  37. 37
    John S. Bradley, Infectious Diseases of the Fetus and Newborn Infant, 2006,

    CrossRef

  38. 38
    Patrizia Farci, Hepatitis D,
  39. 39
    John Marston Taylor, Hepatitis Delta Virus, eLS,
  40. 40
    John M Taylor, Hepatitis Delta Virus, eLS,
  41. 41
    Zaigham Abbas, Muhammad Arsalan Khan, Mohammad Salih, Wasim Jafri, Interferon alpha for chronic hepatitis D, The Cochrane Library,
  42. 42
    Zaigham Abbas, Mohammad Salih, Wasim Jafri, Interferon-alpha for hepatitis D, The Cochrane Library,
  43. 43
    Alessia Ciancio, Mario Rizzetto, Treatment of Hepatitis D,